PIK3R4
gene geneOn this page
Also known as VPS15p150
Summary
PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4, HGNC:8982) is a protein-coding gene on chromosome 3q22.1, encoding Phosphoinositide 3-kinase regulatory subunit 4 (Q99570). Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of…. It is a selective cancer dependency (DepMap: 38.9% of cell lines).
Predicted to enable protein serine/threonine kinase activity. Involved in several processes, including early endosome to late endosome transport; phosphatidylinositol 3-kinase/protein kinase B signal transduction; and phosphatidylinositol-3-phosphate biosynthetic process. Located in ciliary basal body; intercellular bridge; and late endosome. Part of phosphatidylinositol 3-kinase complex, class III.
Source: NCBI Gene 30849 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 189 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 38.9% of screened cell lines
- MANE Select transcript:
NM_014602
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8982 |
| Approved symbol | PIK3R4 |
| Name | phosphoinositide-3-kinase regulatory subunit 4 |
| Location | 3q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | VPS15, p150 |
| Ensembl gene | ENSG00000196455 |
| Ensembl biotype | protein_coding |
| OMIM | 602610 |
| Entrez | 30849 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 7 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000356763, ENST00000504834, ENST00000507330, ENST00000508273, ENST00000511760, ENST00000512362, ENST00000512430, ENST00000512677, ENST00000893859, ENST00000893860, ENST00000954554
RefSeq mRNA: 1 — MANE Select: NM_014602
NM_014602
CCDS: CCDS3067
Canonical transcript exons
ENST00000356763 — 20 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000778202 | 130735869 | 130736002 |
| ENSE00000778205 | 130728463 | 130728684 |
| ENSE00000778207 | 130718389 | 130718534 |
| ENSE00000778208 | 130716396 | 130716599 |
| ENSE00000778209 | 130708291 | 130708492 |
| ENSE00000778210 | 130706948 | 130707135 |
| ENSE00000778211 | 130705561 | 130705771 |
| ENSE00000778212 | 130703723 | 130703888 |
| ENSE00000778213 | 130690490 | 130690654 |
| ENSE00001048139 | 130733548 | 130734130 |
| ENSE00001078058 | 130744486 | 130745264 |
| ENSE00001151964 | 130730308 | 130730442 |
| ENSE00001151979 | 130746318 | 130746829 |
| ENSE00001431034 | 130678934 | 130679485 |
| ENSE00003473754 | 130723414 | 130723587 |
| ENSE00003491621 | 130684250 | 130684381 |
| ENSE00003605957 | 130681491 | 130681591 |
| ENSE00003670145 | 130680613 | 130680721 |
| ENSE00003672366 | 130680977 | 130681065 |
| ENSE00003684151 | 130686211 | 130686422 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 92.88.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.2763 / max 238.3430, expressed in 1803 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 44577 | 17.5527 | 1802 |
| 44578 | 0.5468 | 328 |
| 44575 | 0.1184 | 42 |
| 44576 | 0.0584 | 26 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 92.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.34 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.93 | gold quality |
| colonic epithelium | UBERON:0000397 | 91.59 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.33 | gold quality |
| pituitary gland | UBERON:0000007 | 91.31 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.98 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 90.57 | gold quality |
| ventricular zone | UBERON:0003053 | 90.52 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.44 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.14 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 90.01 | gold quality |
| right lung | UBERON:0002167 | 89.88 | gold quality |
| tibial nerve | UBERON:0001323 | 89.85 | gold quality |
| thyroid gland | UBERON:0002046 | 89.76 | gold quality |
| upper lobe of lung | UBERON:0008948 | 89.67 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.62 | gold quality |
| skin of leg | UBERON:0001511 | 89.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.49 | gold quality |
| liver | UBERON:0002107 | 89.42 | gold quality |
| right ovary | UBERON:0002118 | 89.41 | gold quality |
| right coronary artery | UBERON:0001625 | 89.28 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.22 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.18 | gold quality |
| ectocervix | UBERON:0012249 | 89.15 | gold quality |
| caudate nucleus | UBERON:0001873 | 89.10 | gold quality |
| corpus epididymis | UBERON:0004359 | 89.07 | gold quality |
| putamen | UBERON:0001874 | 89.06 | gold quality |
| right uterine tube | UBERON:0001302 | 88.94 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.13 |
| E-MTAB-7249 | no | 145.09 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting PIK3R4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-7844-5P | 99.55 | 68.56 | 1428 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-5583-3P | 99.06 | 65.68 | 1018 |
| HSA-MIR-605-5P | 98.79 | 68.24 | 1161 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 38.9% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 7)
- hVps15, but not Ca2+/CaM, is required for the activity and regulation of hVps34 in mammalian cells (PMID:18957027)
- A specific sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates both receptor degradation and cytokinesis, whereas ATG14L, a PI3K-III subunit involved in autophagy, is not required. (PMID:20643123)
- High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia. (PMID:25840748)
- A missense mutation in PIK3R4 (phosphoinositide 3-kinase regulatory subunit 4, named VPS15) in a family with a ciliopathy phenotype is identified. Besides being required for trafficking and autophagy, we show that VPS15 regulates primary cilium length in human fibroblasts. (PMID:27882921)
- Both Danon Disease and glycogen storage disease type II show accumulation and altered localization of VPS15 in autophagy-incompetent fibers. However, TFEB displays a different pattern between these two lysosomal storage diseases (PMID:28102838)
- The mutations in VPS15 are associated with cortical atrophy and epilepsy in humans. (PMID:29311744)
- Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagy. (PMID:34121209)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pik3r4 | ENSDARG00000060469 |
| mus_musculus | Pik3r4 | ENSMUSG00000032571 |
| rattus_norvegicus | Pik3r4 | ENSRNOG00000013669 |
| drosophila_melanogaster | Vps15 | FBGN0260935 |
| caenorhabditis_elegans | WBGENE00014151 |
Protein
Protein identifiers
Phosphoinositide 3-kinase regulatory subunit 4 — Q99570 (reviewed: Q99570)
Alternative names: PI3-kinase p150 subunit, Phosphoinositide 3-kinase adaptor protein
All UniProt accessions (4): D6RAC3, D6RBB7, D6RJ98, Q99570
UniProt curated annotations — full annotation on UniProt →
Function. Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2.
Subunit / interactions. Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol 3-kinase) complex the core of which is composed of the catalytic subunit PIK3C3, the regulatory subunit PIK3R4 and BECN1 associating with additional regulatory/auxiliary subunits to form alternative complex forms. Alternative complex forms containing a fourth regulatory subunit in a mutually exclusive manner are PI3K complex I (PI3KC3-C1) containing ATG14, and PI3K complex II (PI3KC3-C2) containing UVRAG. PI3KC3-C1 displays a V-shaped architecture with PIK3R4 serving as a bridge between PIK3C3 and the ATG14:BECN1 subcomplex. Both, PI3KC3-C1 and PI3KC3-C2, can associate with further regulatory subunits, such as RUBCN, SH3GLB1/Bif-1, AMBRA1 and NRBF2. PI3KC3-C1 probably associates with PIK3CB. Interacts with RAB7A in the presence of PIK3C3/VPS34. Interacts with NRBF2. Interacts with ARMC3.
Subcellular location. Late endosome. Cytoplasmic vesicle. Autophagosome. Membrane.
Tissue specificity. Ubiquitously expressed.
Post-translational modifications. Myristoylated. Probably autophosphorylated.
Similarity. Belongs to the protein kinase superfamily. Ser/Thr protein kinase family.
RefSeq proteins (1): NP_055417* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000719 | Prot_kinase_dom | Domain |
| IPR001680 | WD40_rpt | Repeat |
| IPR008271 | Ser/Thr_kinase_AS | Active_site |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR021133 | HEAT_type_2 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR045162 | Vps15-like | Family |
| IPR055231 | PIK3R4-like_middle | Domain |
Pfam: PF00069, PF00400, PF22956
Catalyzed reactions (Rhea), 2 shown:
- L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+) (RHEA:17989)
- L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+) (RHEA:46608)
UniProt features (148 total): helix 57, strand 45, turn 11, repeat 10, sequence variant 8, modified residue 5, region of interest 2, binding site 2, sequence conflict 2, initiator methionine 1, chain 1, compositionally biased region 1, active site 1, domain 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
14 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9MHF | ELECTRON MICROSCOPY | 2.73 |
| 9RX5 | ELECTRON MICROSCOPY | 3.15 |
| 9MHG | ELECTRON MICROSCOPY | 3.2 |
| 9RX6 | ELECTRON MICROSCOPY | 3.52 |
| 13BV | ELECTRON MICROSCOPY | 3.77 |
| 9RX8 | ELECTRON MICROSCOPY | 3.87 |
| 9RX9 | ELECTRON MICROSCOPY | 3.99 |
| 9RXA | ELECTRON MICROSCOPY | 4 |
| 9RXB | ELECTRON MICROSCOPY | 4.03 |
| 9MHH | ELECTRON MICROSCOPY | 4.5 |
| 9C82 | ELECTRON MICROSCOPY | 6.84 |
| 7BL1 | ELECTRON MICROSCOPY | 9.8 |
| 9S47 | ELECTRON MICROSCOPY | 9.88 |
| 8SOR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99570-F1 | 78.47 | 0.33 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 148 (proton acceptor)
Ligand- & substrate-binding residues (2): 32–40; 53
Post-translational modifications (6): 808, 813, 853, 865, 1316, 2
Function
Pathways and Gene Ontology
Reactome pathways
12 pathways
| ID | Pathway |
|---|---|
| R-HSA-109704 | PI3K Cascade |
| R-HSA-1632852 | Macroautophagy |
| R-HSA-1660514 | Synthesis of PIPs at the Golgi membrane |
| R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane |
| R-HSA-1660517 | Synthesis of PIPs at the late endosome membrane |
| R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade |
| R-HSA-5668599 | RHO GTPases Activate NADPH Oxidases |
| R-HSA-9679504 | Translation of Replicase and Assembly of the Replication Transcription Complex |
| R-HSA-9694676 | Translation of Replicase and Assembly of the Replication Transcription Complex |
| R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
| R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| R-HSA-9920951 | Dengue virus modulates apoptosis |
MSigDB gene sets: 251 (showing top):
E2F_Q4_01, REACTOME_SIGNALING_BY_INSULIN_RECEPTOR, GOBP_REGULATION_OF_AUTOPHAGY, GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, GOBP_LYSOSOMAL_TRANSPORT, GU_PDEF_TARGETS_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, GOBP_PROTEIN_TARGETING, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_VACUOLAR_TRANSPORT
GO Biological Process (15): pexophagy (GO:0000425), protein phosphorylation (GO:0006468), protein targeting to lysosome (GO:0006622), protein targeting to vacuole (GO:0006623), regulation of autophagy (GO:0010506), regulation of macroautophagy (GO:0016241), regulation of cytokinesis (GO:0032465), receptor catabolic process (GO:0032801), phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092), cellular response to glucose starvation (GO:0042149), phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491), early endosome to late endosome transport (GO:0045022), late endosome to vacuole transport (GO:0045324), autophagosome maturation (GO:0097352), macroautophagy (GO:0016236)
GO Molecular Function (8): protein kinase activity (GO:0004672), protein serine/threonine kinase activity (GO:0004674), ATP binding (GO:0005524), protein serine kinase activity (GO:0106310), nucleotide binding (GO:0000166), protein binding (GO:0005515), kinase activity (GO:0016301), transferase activity (GO:0016740)
GO Cellular Component (18): late endosome (GO:0005770), autophagosome (GO:0005776), cytosol (GO:0005829), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), membrane (GO:0016020), phagocytic vesicle membrane (GO:0030670), phosphatidylinositol 3-kinase complex, class III, type I (GO:0034271), phosphatidylinositol 3-kinase complex, class III, type II (GO:0034272), phosphatidylinositol 3-kinase complex, class III (GO:0035032), ciliary basal body (GO:0036064), intercellular bridge (GO:0045171), nucleus-vacuole junction (GO:0071561), cytoplasm (GO:0005737), endosome (GO:0005768), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410)
Reactome top-level categories
Rollup of top-10 pathways:
| Category | Pathways |
|---|---|
| PI Metabolism | 3 |
| IRS-mediated signalling | 1 |
| Autophagy | 1 |
| Toll-like Receptor Cascades | 1 |
| RHO GTPase Effectors | 1 |
| SARS-CoV-1 Infection | 1 |
| Early SARS-CoV-2 Infection Events | 1 |
| SARS-CoV-2-host interactions | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Dengue Virus-Host Interactions | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| macroautophagy | 3 |
| cytoplasm | 3 |
| vacuolar transport | 2 |
| autophagy | 2 |
| protein kinase activity | 2 |
| cytoskeleton | 2 |
| phosphatidylinositol 3-kinase complex, class III | 2 |
| autophagy of peroxisome | 1 |
| phosphorylation | 1 |
| protein modification process | 1 |
| protein targeting to vacuole | 1 |
| lysosomal transport | 1 |
| protein localization to lysosome | 1 |
| protein targeting | 1 |
| intracellular protein transport | 1 |
| protein localization to vacuole | 1 |
| establishment of protein localization to vacuole | 1 |
| regulation of catabolic process | 1 |
| regulation of autophagy | 1 |
| cytokinesis | 1 |
| regulation of cell cycle process | 1 |
| regulation of cell division | 1 |
| macromolecule catabolic process | 1 |
| receptor metabolic process | 1 |
| phosphatidylinositol phosphate biosynthetic process | 1 |
| cellular response to starvation | 1 |
| intracellular signaling cassette | 1 |
| vesicle-mediated transport between endosomal compartments | 1 |
| intercellular transport | 1 |
| vesicle-mediated transport | 1 |
| protein-containing complex disassembly | 1 |
| autophagosome assembly | 1 |
| kinase activity | 1 |
| phosphotransferase activity, alcohol group as acceptor | 1 |
| catalytic activity, acting on a protein | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
Protein interactions and networks
STRING
2004 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PIK3R4 | ATG14 | Q6ZNE5 | 999 |
| PIK3R4 | PIK3C3 | Q8NEB9 | 999 |
| PIK3R4 | UVRAG | Q9P2Y5 | 999 |
| PIK3R4 | BECN1 | Q14457 | 999 |
| PIK3R4 | AMBRA1 | Q9C0C7 | 996 |
| PIK3R4 | NRBF2 | Q96F24 | 995 |
| PIK3R4 | RUBCN | Q92622 | 980 |
| PIK3R4 | BECN2 | A8MW95 | 978 |
| PIK3R4 | SH3GLB1 | Q9Y371 | 945 |
| PIK3R4 | ATG7 | O95352 | 930 |
| PIK3R4 | ATG13 | O75143 | 916 |
| PIK3R4 | ATG5 | Q9H1Y0 | 893 |
| PIK3R4 | ATG16L1 | Q676U5 | 880 |
| PIK3R4 | BNIP1 | Q12981 | 876 |
| PIK3R4 | RB1CC1 | Q8TDY2 | 872 |
IntAct
139 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATG14 | BECN1 | psi-mi:“MI:0915”(physical association) | 0.980 |
| ATG14 | BECN1 | psi-mi:“MI:0914”(association) | 0.980 |
| UVRAG | BECN1 | psi-mi:“MI:0915”(physical association) | 0.970 |
| BECN1 | PIK3C3 | psi-mi:“MI:0915”(physical association) | 0.970 |
| UVRAG | BECN1 | psi-mi:“MI:0914”(association) | 0.970 |
| BECN1 | PIK3C3 | psi-mi:“MI:0914”(association) | 0.970 |
| PIK3C3 | BECN1 | psi-mi:“MI:0914”(association) | 0.970 |
| ATG14 | PIK3C3 | psi-mi:“MI:0914”(association) | 0.950 |
| RUBCN | BECN1 | psi-mi:“MI:0914”(association) | 0.920 |
| NRBF2 | PIK3R4 | psi-mi:“MI:0915”(physical association) | 0.920 |
| NRBF2 | BECN1 | psi-mi:“MI:0914”(association) | 0.860 |
| NRBF2 | PIK3C3 | psi-mi:“MI:0914”(association) | 0.850 |
| PIK3C3 | NRBF2 | psi-mi:“MI:0914”(association) | 0.850 |
BioGRID (196): PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-RNA), PIK3R4 (Affinity Capture-RNA), PIK3R4 (Affinity Capture-Western), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Co-fractionation), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IB93, A0A2R8QPS5, A1Z7K9, A2QW83, A4RF51, A5DAD0, A6QR55, B0X2V9, F6V6I0, F6Z5C0, O13046, O17468, P0C0R5, P0C581, P35123, P53015, Q05B30, Q09798, Q0J7U6, Q0WV90, Q10NY2, Q13107, Q1E873, Q20059, Q27GK7, Q4WHP6, Q5NBT9, Q5R4F4, Q5R9I3, Q5RCD3, Q5ZMV9, Q6CMN5, Q6DIP5, Q754X1, Q7ZVL2, Q7ZX22, Q84JM4, Q8R5H1, Q8VD65, Q94AI7
Diamond homologs: A8X5H5, F4ICB6, F4JY12, G4NH08, O14132, O42900, P0C0R5, P18265, P18266, P18431, P22219, P43292, P49840, P49841, P51136, P51137, P54665, P54685, Q00534, Q09499, Q10452, Q12222, Q2NL51, Q2V419, Q38774, Q388M1, Q3S406, Q40518, Q54XJ4, Q5R9I3, Q5YJC2, Q64261, Q6BRY2, Q6CCB0, Q6FRH8, Q6I5Y0, Q6ZAG3, Q7XQP4, Q8SW92, Q8VD65
SIGNOR signaling
6 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NRBF2 | “down-regulates activity” | PIK3R4 | binding |
| PIK3R4 | up-regulates | PIK3C3 | binding |
| RAB5A | “up-regulates activity” | PIK3R4 | binding |
| PIK3R4 | “up-regulates activity” | PIK3C3 | binding |
| PIK3R4 | “form complex” | “Vps34 Complex I” | binding |
| PIK3R4 | “form complex” | “Vps34 Complex II” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 134 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 5 | 22.1× | 3e-04 |
| Intrinsic Pathway for Apoptosis | 5 | 16.4× | 8e-04 |
| Macroautophagy | 11 | 14.3× | 1e-07 |
| SARS-CoV-2-host interactions | 8 | 10.7× | 2e-04 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 6 | 10.4× | 1e-03 |
| Autophagy | 6 | 10.0× | 1e-03 |
| SARS-CoV-1-host interactions | 5 | 9.9× | 4e-03 |
| SARS-CoV-1 Infection | 6 | 9.6× | 1e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| autophagosome maturation | 7 | 21.6× | 8e-06 |
| autophagosome assembly | 9 | 17.7× | 7e-07 |
| mitophagy | 6 | 16.7× | 3e-04 |
| cellular response to glucose starvation | 5 | 14.8× | 2e-03 |
| macroautophagy | 5 | 10.6× | 9e-03 |
| autophagy | 8 | 7.7× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
189 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 153 |
| Likely benign | 5 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3192 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:130679497:T:TC | acceptor_gain | 1.0000 |
| 3:130680608:AGTAC:A | donor_loss | 1.0000 |
| 3:130680609:GTA:G | donor_loss | 1.0000 |
| 3:130680612:C:CA | donor_loss | 1.0000 |
| 3:130680720:ACC:A | acceptor_loss | 1.0000 |
| 3:130680722:CTAGG:C | acceptor_loss | 1.0000 |
| 3:130680723:T:A | acceptor_loss | 1.0000 |
| 3:130681067:T:C | acceptor_gain | 1.0000 |
| 3:130684245:CTTAC:C | donor_loss | 1.0000 |
| 3:130684246:TTACC:T | donor_loss | 1.0000 |
| 3:130684248:ACCT:A | donor_loss | 1.0000 |
| 3:130684249:C:CG | donor_loss | 1.0000 |
| 3:130684249:CCTG:C | donor_gain | 1.0000 |
| 3:130684377:TGTAC:T | acceptor_gain | 1.0000 |
| 3:130684379:TAC:T | acceptor_gain | 1.0000 |
| 3:130684379:TACC:T | acceptor_loss | 1.0000 |
| 3:130684380:AC:A | acceptor_gain | 1.0000 |
| 3:130684381:CC:C | acceptor_gain | 1.0000 |
| 3:130684382:C:CC | acceptor_gain | 1.0000 |
| 3:130684382:C:T | acceptor_gain | 1.0000 |
| 3:130684382:CTTA:C | acceptor_loss | 1.0000 |
| 3:130684383:T:C | acceptor_gain | 1.0000 |
| 3:130684383:T:TC | acceptor_gain | 1.0000 |
| 3:130690485:GATA:G | donor_loss | 1.0000 |
| 3:130690486:ATAC:A | donor_loss | 1.0000 |
| 3:130690487:TACC:T | donor_loss | 1.0000 |
| 3:130690488:ACC:A | donor_loss | 1.0000 |
| 3:130690489:CCTG:C | donor_gain | 1.0000 |
| 3:130690531:AGAAG:A | donor_gain | 1.0000 |
| 3:130690650:TAGAT:T | acceptor_gain | 1.0000 |
AlphaMissense
8975 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:130679323:A:G | W1357R | 1.000 |
| 3:130679323:A:T | W1357R | 1.000 |
| 3:130679338:C:A | G1352W | 1.000 |
| 3:130680717:A:G | W1268R | 1.000 |
| 3:130680717:A:T | W1268R | 1.000 |
| 3:130681562:A:G | W1213R | 1.000 |
| 3:130681562:A:T | W1213R | 1.000 |
| 3:130684341:G:C | F1172L | 1.000 |
| 3:130684341:G:T | F1172L | 1.000 |
| 3:130684342:A:C | F1172C | 1.000 |
| 3:130684342:A:G | F1172S | 1.000 |
| 3:130684343:A:C | F1172V | 1.000 |
| 3:130684343:A:G | F1172L | 1.000 |
| 3:130684343:A:T | F1172I | 1.000 |
| 3:130684344:C:A | R1171S | 1.000 |
| 3:130684344:C:G | R1171S | 1.000 |
| 3:130684345:C:A | R1171M | 1.000 |
| 3:130684345:C:G | R1171T | 1.000 |
| 3:130684350:G:C | D1169E | 1.000 |
| 3:130684350:G:T | D1169E | 1.000 |
| 3:130684351:T:A | D1169V | 1.000 |
| 3:130684351:T:C | D1169G | 1.000 |
| 3:130684351:T:G | D1169A | 1.000 |
| 3:130684352:C:G | D1169H | 1.000 |
| 3:130684355:A:G | W1168R | 1.000 |
| 3:130684355:A:T | W1168R | 1.000 |
| 3:130684381:C:T | G1159D | 1.000 |
| 3:130686219:A:G | L1156P | 1.000 |
| 3:130686289:A:G | W1133R | 1.000 |
| 3:130686289:A:T | W1133R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000021511 (3:130685019 A>G), RS1000101900 (3:130704703 T>C), RS1000128103 (3:130732073 G>C,T), RS1000165057 (3:130703167 G>T), RS1000182024 (3:130742308 A>C), RS1000280003 (3:130697552 G>C,T), RS1000282514 (3:130742551 G>A,C), RS1000291649 (3:130690346 A>C), RS1000325158 (3:130711701 A>G), RS1000361252 (3:130724980 T>C), RS1000392843 (3:130737077 A>G), RS1000473057 (3:130739202 G>A,C), RS1000489583 (3:130729148 A>C), RS1000526314 (3:130743693 C>T), RS1000594975 (3:130691568 T>C)
Disease associations
OMIM: gene MIM:602610 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009091_5 | Abdominal aortic calcification levels | 5.000000e-07 |
| GCST010002_439 | Refractive error | 5.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010272 | abdominal aortic calcification measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (2): CHEMBL2189144 (SINGLE PROTEIN), CHEMBL5483084 (PROTEIN COMPLEX)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — Phosphatidylinositol kinases
ChEMBL bioactivities
2 potent at pChembl≥5 of 3 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.60 | IC50 | 25 | nM | CHEMBL3913746 |
PubChem BioAssay actives
2 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 1-[[5-[2-[(2-chloro-4-pyridinyl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol | 2017597: Inhibition of recombinant human Vps34-Vps15 complex expressed in insect cells assessed as reduction in PtdIns phosphorylation in presence of gamma32P-ATP by radioactive assay | ic50 | 0.0250 | uM |
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, decreases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| zinc chloride | increases expression | 1 |
| sodium arsenite | affects binding, increases reaction | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| mesotrione | affects methylation, increases abundance | 1 |
| abrine | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Herbicides | affects methylation, increases abundance | 1 |
| Ivermectin | decreases expression | 1 |
| Mercury | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Piroxicam | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Thiram | decreases expression | 1 |
| Zinc | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
ChEMBL screening assays
6 unique, capped per target: 6 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2211984 | Binding | Inhibition of PIK3R4 | Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease. — Bioorg Med Chem Lett |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B7YS | Abcam Raji PIK3R4 KO | Cancer cell line | Male |
| CVCL_B9ZH | Abcam THP-1 PIK3R4 KO | Cancer cell line | Male |
| CVCL_C7B6 | Abcam PC-3 PIK3R4 KO | Cancer cell line | Male |
| CVCL_E3KC | HeLa S3 PIK3R4 KO clone #89 | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.